Samuel Chang Selected Research

Samuel Chang Research Topics

5	Neoplasms (Cancer) 02/2016 - 06/2010
5	Hepatocellular Carcinoma (Hepatoma) 09/2015 - 05/2008
3	Esophageal Neoplasms (Esophageal Cancer) 04/2016 - 01/2016
2	Rectal Neoplasms (Rectal Cancer) 12/2016 - 12/2015
1	Prostatic Neoplasms (Prostate Cancer) 11/2021
1	Thyroid Neoplasms (Thyroid Cancer) 01/2018
1	Adenocarcinoma 04/2016
1	Disease Progression 11/2013
1	End Stage Liver Disease 11/2013
1	Legg-Calve-Perthes Disease (Perthes Disease) 09/2013
1	Congenital Abnormalities (Deformity) 09/2013
1	Non-alcoholic Fatty Liver Disease 05/2013
1	Fibrosis (Cirrhosis) 05/2013
1	Hyperinsulinism (Hyperinsulinemia) 05/2013
1	Insulin Resistance 05/2013
1	Body Weight (Weight, Body) 11/2008

3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2016 - 12/2015
2	IodineIBA 01/2018 - 11/2008
2	Fluorine-18IBA 12/2016 - 02/2016
2	Glucose (Dextrose)FDA LinkGeneric 02/2016 - 01/2016
2	Long Noncoding RNAIBA 02/2016 - 02/2016
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 05/2013
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2018
1	Glutamine (L-Glutamine)FDA Link 02/2016
1	Fibrinogen (Factor I)FDA Link 02/2016
1	Fetal Proteins (Fetoprotein)IBA 11/2013
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2013
1	di-beta-(morpholinoethyl)selenide (MOSE)IBA 09/2013
1	ferric oxide (iron oxide)IBA 02/2009
1	Ethanol (Ethyl Alcohol)IBA 05/2008
1	ferumoxides (Feridex)FDA Link 05/2008